Submitted by Anonymous (not verified) on 3 November 2026 - 16:35
Human medicines European public assessment report (EPAR): Veanibek (previously Miglustat Gen.Orph), miglustat, Date of authorisation: 09/11/2017, Revision: 13, Status: Authorised
Source: